TrialBritish journal of cancer2008

GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.

D M Kweekel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.